IntERact Behavior Intervention for Firearm Carrying
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new behavioral program called IntERact to determine its effectiveness in reducing risky firearm carrying among young people. Participants will either receive standard care with resources or engage in three remote therapy sessions and use a supporting smartphone app. The trial seeks youth aged 16 to 30 from Flint or Saginaw who have carried a firearm in the past three months and own a smartphone. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could lead to safer communities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the IntERact Behavioral Intervention is safe?
Research shows that the IntERact program aims to help young people reduce risky behavior with firearms. This program uses methods like motivational interviewing and cognitive behavioral skills training, which most participants find manageable.
Past studies have shown no safety issues with this program. Since it doesn't involve medications, the chance of physical side effects remains very low. Instead, it helps change behavior and thought patterns through conversation and support.
The trial is in a "Not Applicable" phase, indicating it doesn't involve testing a new drug or medical device. This phase usually focuses on the program's effectiveness rather than safety concerns.
Overall, participants can expect a safe experience, as the program includes remote therapy sessions and app content, both of which are non-invasive.12345Why are researchers excited about this trial?
Researchers are excited about the IntERact program because it offers a fresh approach to reducing firearm carrying among young people. Unlike traditional methods that might focus solely on punishment or counseling, IntERact combines motivational interviewing, cognitive behavioral skills training, and care management. This innovative approach is delivered remotely, making it more accessible, and is supported by a smartphone app that provides ongoing therapeutic content. These features not only enhance engagement but could potentially lead to more effective and lasting behavior change.
What evidence suggests that the IntERact Behavioral Intervention is effective for reducing risky firearm carriage among youth?
Research has shown that the IntERact program, which participants in this trial may receive, might help reduce risky gun carrying among high-risk youth. This program uses motivational talks, training in thinking and behavior skills, and support from care managers. These methods have proven effective in helping people make better decisions and manage stress. Early results suggest that similar programs can lead to fewer emergency room visits for violent injuries, reduced drug and alcohol use, and improved mental health. Although this study is ongoing, the IntERact program is based on techniques that have succeeded in other programs.12356
Who Is on the Research Team?
Patrick Carter, M.D.
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for Flint or Saginaw youth aged 16-24 who have carried a firearm in the past 3 months and own a smartphone. Participants must be able to consent (or provide assent with parental consent if under 18) and not be incarcerated, mentally incapacitated, or seeking emergency care for suicide, sexual assault, or child abuse.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive three remotely delivered behavioral therapy sessions integrating motivational interviewing, cognitive behavioral therapy, and care management, supported by a smartphone app.
Follow-up
Participants are monitored for changes in risky firearm behaviors, aggression, and victimization at 3 and 6 months post-baseline.
What Are the Treatments Tested in This Trial?
Interventions
- IntERact
IntERact is already approved in United States for the following indications:
- Reducing risky firearm behaviors among youth
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator